Delivery Order SPE2DB20D2014-SPE2DB25FA70S
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,139.42 firm fixed-price delivery order is for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has an ultimate completion date of December 31, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,537.92 firm fixed price delivery order is for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 30, 2024. This award is a part of Amerisourcebergen's larger...
This federal contract award, valued at $3,063.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REVATIO 20 MG TABLET 90S, a medication used for the treatment of pulmonary arterial hypertension. The contract has an ultimate completion date of December 17, 2024 and is a Firm Fixed Price contract. This award is not associated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $6,994.44, is for the delivery of Revatio 20 mg tablets, a medication used to treat pulmonary arterial hypertension.
The contract is a Delivery Order with a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating it was awarded on a full and open competition basis. The contract has an ultimate completion...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $23,283.83, is for the delivery of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation.
Amerisourcebergen Drug Corp holds a significant...
This federal contract award, SPE2DB20D1109|SPE2DB25FN32V, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $14,833.03 firm fixed price delivery order is for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a...
This federal contract award is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed price contract, valued at $3,756.30, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,977.07 firm fixed-price delivery order is for REVATIO 20 MG TABLET 90S, a cardiovascular medication, with a completion date of December 17, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $2,331.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product.
The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 12, 2024. It is not designated with any set-aside requirements, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,549.85 firm-fixed-price delivery order is for the supply of REVATIO 20 MG TABLET 90S, a pharmaceutical product, with a completion date of November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...